MENU

Sponsoring Associations:

Sponsoring Organization:

Lead Sponsoring Publications:

Sponsoring Publications:

Web Partners:

顧問委員會

匯聚了最先進的專家。

• Li Chen, Ph.D., Chief Scientific Officer, Roche R&D Center (China) Ltd.
• Ling Chen, Ph.D., Director General, Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences
• Shaoyu Chen, Senior Counsel, Development & Regulatory Law Group, Amgen Inc.
• Joong Myung Cho, Ph.D., President & CEO, CrystalGenomics, Inc. (South Korea)
• Ming Guo, Ph.D., Vice President, Pharmaceutical Sciences & Manufacturing; General Manager, Ascenta (Shanghai) R&D Center; Ascenta Therapeutics, Inc.
• Canwen Jiang, M.D., Ph.D., Head of Genzyme Science (R&D) China, Genzyme
• Xian-Ping Lu, CEO & Chief Scientific Officer, Shenzhen Chipscreen Biosciences Ltd.
• Eric Meyers, President, China Preclinical Management Services
• Purvish M. Parikh, Ph.D., Professor, Medical Oncology, Indian Co-operative Oncology Network (ICON-ARO)
• Rickey Pate, MBA, JD, Director of Global Tax, Eli Lilly and Company
• Sofie Qiao, Ph.D., President and COO, LEAD Therapeutics, Inc.
• Jun Ren, M.D., Ph.D., Executive Director, Clinical Trials Coordination, Peking University School of Oncology / Beijing Cancer Hospital
• Greg B. Scott, President and Founder, ChinaBio® Accelerator/Life Science Angels
• Michael Shi, Director and Biomarker Project Leader, Exploratory Oncology Development,  Novartis Oncology
• Mansour Yaïch, Ph.D., Vaccine Development Director, PATH
• Zhengyu Yuan, Ph.D., President and CEO, MicuRx Pharmaceuticals, Inc.
• Benny Zee, Ph.D., Assistant Dean of Research for the Faculty of Medicine, Director of the Centre for Clinical Trials, School of Public Health, Chinese University of Hong Kong (CUHK)
• Ji Zhang, Ph.D., Director, DMPK, GlaxoSmithKline R&D China
• Haizhou Zhang, Ph.D., Vice President, China Operations, China Preclinical Management Services
• Guoxin Zhu, Ph.D., CSO, Head of China Chemistry, Discovery Chemistry Research Technology, Eli Lilly Asia, Inc., Shanghai Rep. Office

語言選擇